Abnova Taiwan Corp
TWSE:4133
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Abnova Taiwan Corp
Other Liabilities
Abnova Taiwan Corp
Other Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Abnova Taiwan Corp
TWSE:4133
|
Other Liabilities
NT$724k
|
CAGR 3-Years
11%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
14%
|
|
Abnova Taiwan Corp
Glance View
Abnova Taiwan Corp. is engaged in researching, developing, manufacturing and selling antibodies. The company is headquartered in Taipei City, Taipei. The company went IPO on 2008-05-27. The firm's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The firm's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.
See Also
What is Abnova Taiwan Corp's Other Liabilities?
Other Liabilities
724k
TWD
Based on the financial report for Dec 31, 2025, Abnova Taiwan Corp's Other Liabilities amounts to 724k TWD.
What is Abnova Taiwan Corp's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
14%
Over the last year, the Other Liabilities growth was 68%. The average annual Other Liabilities growth rates for Abnova Taiwan Corp have been 11% over the past three years , -27% over the past five years , and 14% over the past ten years .
